The slip
PARKINSON RECEIPTno. 4663
20 Oct 2026, 22:37 UTCdopamine neurons, braak
predictionCCDC85C in dopamine neurons tracks Braak Lewy-body stage
registered033bb3bdb2cf2c90
discovery-0.35 p=0.358 n=9
replication-0.41 p=0.276 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.35, p 0.358)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT22ea18f31eb8729513d9d31e…
follows 86510eb75bf8…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4663: CCDC85C in dopamine neurons, braak
- power
- full sample -0.41 (p 0.089, n 18), 95% CI -0.74 to +0.07. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.41 (p 0.089, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.52 (p 0.027, n 18). not the mix.
- skeptic
- leave-one-out range -0.58 to -0.34, sign flips 0; without severely affected donors -0.41 (p 0.089, n 18). robust.
- cell type
- strongest in oligodendrocytes: -0.71 (p 0.0011, n 18) vs -0.41 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CCDC85C in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up CCDC85C · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.43 p 0.131 (needs p < 4.3e-4)